326
Views
1
CrossRef citations to date
0
Altmetric
Review Articles

Bacterial cyclomodulins: types and roles in carcinogenesis

, , & ORCID Icon
Pages 42-66 | Received 30 Apr 2020, Accepted 05 Jun 2021, Published online: 15 Jul 2021

References

  • Abukhdeir AM, Park BH. 2008. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med. 10:e19–e.
  • Aktories K. 1997. Bacterial toxins that target Rho proteins. J Clin Invest. 99(5):827–829.
  • Altieri F, Grillo C, Maceroni M, Chichiarelli S. 2008. DNA damage and repair: from molecular mechanisms to health implications. Antioxid Redox Signal. 10(5):891–938.
  • Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, Campbell BJ, Abujamel T, Dogan B, Rogers AB, et al. 2012. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 338(6103):120–123.
  • Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 270(30):17771–17777.
  • Bang DD, Madsen M. 2003. Cytolethal distending toxins of Campylobacter jejuni: genetics, structure, mode of action, epidemiology, and the role of CDT in Campylobacter pathogenesis. Genome Lett. 2(1):73–82.
  • Banks KE, Humphreys TL, Li W, Katz BP, Wilkes DS, Spinola SM. 2007. Haemophilus ducreyi partially activates human myeloid dendritic cells. Infect Immun. 75(12):5678–5685.
  • Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou L-VF, Kolettas E, Niforou K, Zoumpourlis VC, et al. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature. 444(7119):633–637.
  • Bernstein H, Bernstein C, Payne CM, Dvorak K. 2009. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 15(27):3329–3340.
  • Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, Bennecke M, Bateman T, Nebelsiek T, Lundgren-May T, Canli O, Schwitalla S, et al. 2009. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 15(2):91–102.
  • Boquet P. 2001. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. Toxicon. 39(11):1673–1680.
  • Bossuet-Greif N, Dubois D, Petit C, Tronnet S, Martin P, Bonnet R, Oswald E, Nougayrède J-P. 2016. Escherichia coli ClbS is a colibactin resistance protein. Mol Microbiol. 99(5):897–908.
  • Boulkroun S, Guenin-Macé L, Thoulouze M-I, Monot M, Merckx A, Langsley G, Bismuth G, Di Bartolo V, Demangel C. 2010. Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events. J Immunol. 184(3):1436–1444.
  • Boyer L, Travaglione S, Falzano L, Gauthier NC, Popoff MR, Lemichez E, Fiorentini C, Fabbri A. 2004. Rac GTPase instructs nuclear factor-kappaB activation by conveying the SCF complex and IkBalpha to the ruffling membranes . Mol Biol Cell. 15(3):1124–1133.
  • Brotherton CA. 2016. Investigations of the biosynthesis and structure of colibactin, a cytotoxin made by human-associated. Escherichia coli.
  • Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, Pezet D, Bonnet R. 2013. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One. 8(2):e56964.
  • Buetow L, Flatau G, Chiu K, Boquet P, Ghosh P. 2001. Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nat Struct Biol. 8(7):584–588.
  • Cadet J, Davies KJ. 2017. Oxidative DNA damage & repair: an introduction. Free Radic Biol Med. 107:2–12.
  • Caprioli A, Donelli G, Falbo V, Possenti R, Roda LG, Roscetti G, Ruggeri FM. 1984. A cell division-active protein from E. coli. Biochem Biophys Res Commun. 118(2):587–593.
  • Caprioli A, Falbo V, Roda L, Ruggeri F, Zona C. 1983. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. Infect Immun. 39(3):1300–1306.
  • Chan A, Fleming T, McGovern E, Chedid M, Miki T, Aaronson S. 1993. Expression cDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product. Mol Cell Biol. 13(2):762–768.
  • Chang PV, Hao L, Offermanns S, Medzhitov R. 2014. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA. 111(6):2247–2252.
  • Coleman ML, Marshall CJ, Olson MF. 2004. RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat Rev Mol Cell Biol. 5(5):355–366.
  • Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. 2009. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 30(7):1073–1081.
  • Cortes-Bratti X, Frisan T, Thelestam M. 2001. The cytolethal distending toxins induce DNA damage and cell cycle arrest. Toxicon. 39(11):1729–1736.
  • Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L, Sauvanet P, Darcha C, Déchelotte P, Bonnet M, et al. 2014. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut. 63(12):1932–1942.
  • Cover TL, Blaser MJ. 1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem. 267(15):10570–10575.
  • Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. 2010. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A. 107(25):11537–11542.
  • Dalmasso G, Cougnoux A, Delmas J, Darfeuille-Michaud A, Bonnet R. 2014. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment. Gut Microbes. 5(5):675–680.
  • de Bernard M, Burroni D, Papini E, Rappuoli R, Telford J, Montecucco C. 1998. Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol. Infect Immun. 66(12):6014–6016.
  • de Martel C, Plummer M, Vignat J, Franceschi S. 2017. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 141(4):664–670.
  • De Rycke J, Gonzalez E, Blanco J, Oswald E, Blanco M, Boivin R. 1990. Evidence for two types of cytotoxic necrotizing factor in human and animal clinical isolates of Escherichia coli. J Clin Microbiol. 28(4):694–699.
  • Del Bel Belluz L, Guidi R, Pateras IS, Levi L, Mihaljevic B, Rouf SF, Wrande M, Candela M, Turroni S, Nastasi C, et al. 2016. The typhoid toxin promotes host survival and the establishment of a persistent asymptomatic infection. PLoS Pathog. 12(4):e1005528.
  • DiRienzo JM. 2014. Cytolethal distending toxin: a unique variation on the AB toxin paradigm. New J Sci. 2014:1–26.
  • Dubois D, Baron O, Cougnoux A, Delmas J, Pradel N, Boury M, Bouchon B, Bringer M-A, Nougayrède J-P, Oswald E, et al. 2011. ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides. J Biol Chem. 286(41):35562–35570.
  • Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. 2005. Diversity of the human intestinal microbial flora. Science. 308(5728):1635–1638.
  • El-Aouar Filho RA, Nicolas A, De Paula Castro TL, Deplanche M, De Carvalho Azevedo VA, Goossens PL, et al. 2017. Heterogeneous family of cyclomodulins: smart weapons that allow bacteria to hijack the eukaryotic cell cycle and promote infections. Front Cell Infect Microbiol. 7:208.
  • Elkahwaji J, Hauke R, Brawner C. 2009. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. Br J Cancer. 101(10):1740–1748.
  • En J, Goto M, Nakanaga K, Higashi M, Ishii N, Saito H, Yonezawa S, Hamada H, Small PLC. 2008. Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (Buruli ulcer) in a murine study. Infect Immun. 76(5):2002–2007.
  • Fabbri A, Travaglione S, Ballan G, Loizzo S, Fiorentini C. 2013. The cytotoxic necrotizing factor 1 from E. coli: a Janus toxin playing with cancer regulators. Toxins. 5(8):1462–1474.
  • Faïs T, Delmas J, Barnich N, Bonnet R, Dalmasso G. 2018. Colibactin: more than a new bacterial toxin. Toxins. 10(4):151.
  • Falbo V, Pace T, Picci L, Pizzi E, Caprioli A. 1993. Isolation and nucleotide sequence of the gene encoding cytotoxic necrotizing factor 1 of Escherichia coli. Infect Immun. 61(11):4909–4914.
  • Fan Y, Mao R, Yang J. 2013. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell. 4(3):176–185.
  • Fedor Y, Vignard J, Nicolau-Travers M-L, Boutet-Robinet E, Watrin C, Salles B, Mirey G. 2013. From single-strand breaks to double-strand breaks during S-phase: a new mode of action of the Escherichia coli cytolethal distending toxin . Cell Microbiol. 15(1):1–15.
  • Ferreri AJ, Govi S, Ponzoni M. 2013. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach. Curr Opin Oncol. 25(5):470–479.
  • Fiorentini C, Fabbri A, Matarrese P, Falzano L, Boquet P, Malorni W. 1997. Hinderance of apoptosis and phagocytic behaviour induced by Escherichia coli cytotoxic necrotizing factor 1: two related activities in epithelial cells. Biochem Biophys Res Commun. 241(2):341–346.
  • Fischer W, Buhrdorf R, Gerland E, Haas R. 2001. Outer membrane targeting of passenger proteins by the vacuolating cytotoxin autotransporter of Helicobacter pylori. Infect Immun. 69(11):6769–6775.
  • Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, Fiorentini C, Boquet P. 1997. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature. 387(6634):729–733.
  • Fowler CC, Chang S-J, Gao X, Geiger T, Stack G, Galán JE. 2017. Emerging insights into the biology of typhoid toxin. Curr Opin Microbiol. 35:70–77.
  • Frisan T, Cortes‐Bratti X, Chaves‐Olarte E, Stenerlöw B, Thelestam M. 2003. The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell Microbiol. 5(10):695–707.
  • Gambhir S, Vyas D, Hollis M, Aekka A, Vyas A. 2015. Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies. World J Gastroenterol. 21(11):3174–3183.
  • García A, Mannion A, Feng Y, Madden CM, Bakthavatchalu V, Shen Z, Ge Z, Fox JG. 2016. Cytotoxic Escherichia coli strains encoding colibactin colonize laboratory mice. Microbes Infect. 18(12):777–786.
  • Gholizadeh P, Eslami H, Kafil HS. 2017. Carcinogenesis mechanisms of Fusobacterium nucleatum. Biomed Pharmacother. 89:918–925.
  • Gonenc A, Ozkan Y, Torun M, Simsek B. 2001. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther. 26(2):141–144.
  • González-Rivera C, Algood HMS, Radin JN, McClain MS, Cover TL. 2012. The intermediate region of Helicobacter pylori VacA is a determinant of toxin potency in a Jurkat T cell assay. Infect Immun. 80(8):2578–2588.
  • González-Rivera C, Gangwer KA, McClain MS, Eli IM, Chambers MG, Ohi MD, Lacy DB, Cover TL. 2010. Reconstitution of Helicobacter pylori VacA toxin from purified components. Biochemistry. 49(27):5743–5752.
  • Grasso F, Frisan T. 2015. Bacterial genotoxins: merging the DNA damage response into infection biology. Biomolecules. 5(3):1762–1782.
  • Griego RD, Rosen T, Orengo IF, Wolf JE. 1995. Dog, cat, and human bites: a review. J Am Acad Dermatol. 33(6):1019–1029.
  • Guenin-Macé L, Carrette F, Asperti-Boursin F, Le Bon A, Caleechurn L, Di Bartolo V, Fontanet A, Bismuth G, Demangel C. 2011. Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression. Proc Natl Acad Sci USA. 108(31):12833–12838.
  • Guidi R, Guerra L, Levi L, Stenerlöw B, Fox JG, Josenhans C, Masucci MG, Frisan T. 2013. Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response . Cell Microbiol. 15(1):98–113.
  • Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, et al. 2015. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 42(2):344–355.
  • Hatakeyama M. 2004. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 4(9):688–694.
  • Hatakeyama M. 2017. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci. 93(4):196–219.
  • Hazes B, Read RJ. 1995. A mosquitocidal toxin with a ricin-like cell-binding domain. Nat Struct Biol. 2(5):358–359.
  • Heywood W, Henderson B, Nair SP. 2005. Cytolethal distending toxin: creating a gap in the cell cycle. J Med Microbiol. 54(Pt 3):207–216.
  • Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S, Higuchi M, Takahashi A, Kurashima Y, Teishikata Y, et al. 2004. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem. 279(17):17205–17216.
  • Hirata Y, Maeda S, Mitsuno Y, Akanuma M, Yamaji Y, Ogura K, Yoshida H, Shiratori Y, Omata M. 2001. Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells. Infect Immun. 69(6):3965–3971.
  • Hoffmann C, Pop M, Leemhuis J, Schirmer J, Aktories K, Schmidt G. 2004. The Yersinia pseudotuberculosis cytotoxic necrotizing factor (CNFY) selectively activates RhoA. J Biol Chem. 279(16):16026–16032.
  • Homburg S, Oswald E, Hacker J, Dobrindt U. 2007. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett. 275(2):255–262.
  • Ito Y, Azuma T, Ito S, Suto H, Miyaji H, Yamazaki Y, Kohli Y, Kuriyama M. 1998. Full-length sequence analysis of the vacA gene from cytotoxic and noncytotoxic Helicobacter pylori. J Infect Dis. 178(5):1391–1398.
  • Jones KR, Whitmire JM, Merrell DS. 2010. A tale of two toxins: Helicobacter pylori CagA and VacA modulate host pathways that impact disease. Front Microbiol. 1:115.
  • Jubelin G, Chavez CV, Taieb F, Banfield MJ, Samba-Louaka A, Nobe R, Nougayrède J-P, Zumbihl R, Givaudan A, Escoubas J-M, et al. 2009. Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One. 4(3):e4855.
  • Karin M. 2006. NF-kappaB and cancer: mechanisms and targets. Mol Carcinog. 45(6):355–361.
  • Khansari N, Shakiba Y, Mahmoudi M. 2009. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov. 3(1):73–80.
  • Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, et al. 2013. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 14(2):207–215.
  • Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. 2011. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res. 711(1–2):193–201.
  • Kunzmann MH, Sieber SA. 2012. Target analysis of α-alkylidene-γ-butyrolactones in uropathogenic E. coli. Mol Biosyst. 8(11):3061–3067.
  • Lacerda HM, Pullinger GD, Lax AJ, Rozengurt E. 1997. Cytotoxic necrotizing factor 1 from Escherichia coli and dermonecrotic toxin from Bordetella bronchiseptica induce p21(rho)-dependent tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 cells . J Biol Chem. 272(14):9587–9596.
  • Lara-Tejero M, Galán JE. 2001. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect Immun. 69(7):4358–4365.
  • Lax AJ. 2005. Opinion: bacterial toxins and cancer-a case to answer? Nat Rev Microbiol. 3(4):343–349.
  • Lax AJ. 2007. New genotoxin shows diversity of bacterial attack mechanisms. Trends Mol Med. 13(3):91–93.
  • Lax AJ, Grigoriadis AE. 2001. Pasteurella multocida toxin: the mitogenic toxin that stimulates signalling cascades to regulate growth and differentiation. Int J Med Microbiol. 291(4):261–268.
  • Lax AJ, Thomas W. 2002. How bacteria could cause cancer: one step at a time. Trends Microbiol. 10(6):293–299.
  • Lebrec H, Ponce R, Preston BD, Iles J, Born TL, Hooper M. 2015. Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk. Curr Med Res Opin. 31(3):557–574.
  • Lee HO, Davidson JM, Duronio RJ. 2009. Endoreplication: polyploidy with purpose. Genes Dev. 23(21):2461–2477.
  • Lee RB, Hassane DC, Cottle DL, Pickett CL. 2003. Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cells. Infect Immun. 71(9):4883–4890.
  • Lee S, Yang Y-A, Milano SK, Nguyen T, Ahn C, Sim JH, Thompson AJ, Hillpot EC, Yoo G, Paulson JC, et al. 2020. Salmonella typhoid toxin PltB subunit and its non-typhoidal Salmonella ortholog confer differential host adaptation and virulence. Cell Host Microbe. 27(6):937–949 e6.
  • Lerm M, Schmidt G, Aktories K. 2000. Bacterial protein toxins targeting rho GTPases. FEMS Microbiol Lett. 188(1):1–6.
  • Li J, Yuan X, Xu L, Wang Y. 2016. Biological function of cytolethal distending toxin (CDT) of Haemophilus parasuis. J Agric Biotech. 24(1):10–17.
  • Liao JB. 2006. Viruses and human cancer. Yale J Biol Med. 79(3-4):115–122.
  • Lim P, Wuenschell GE, Holland V, Lee D-H, Pfeifer GP, Rodriguez H, Termini J. 2004. Peroxyl radical mediated oxidative DNA base damage: implications for lipid peroxidation induced mutagenesis. Biochemistry. 43(49):15339–15348.
  • Liu J-F, Jamieson GG, Drew PA, Zhu G-J, Zhang S-W, Zhu T-N, Shan B-E, Wang Q-Z. 2005. Aspirin induces apoptosis in oesophageal cancer cells by inhibiting the pathway of NF-kappaB downstream regulation of cyclooxygenase-2 . ANZ J Surg. 75(11):1011–1016.
  • Livey I, Wardlaw AC. 1984. Production and properties of Bordetella pertussis heat-labile toxin. J Med Microbiol. 17(1):91–103.
  • Lockman HA, Gillespie RA, Baker BD, Shakhnovich E. 2002. Yersinia pseudotuberculosis produces a cytotoxic necrotizing factor. Infect Immun. 70(5):2708–2714.
  • Louis P, Hold GL, Flint HJ. 2014. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 12(10):661–672.
  • Lyon F. 1994. IARC monographs on the evaluation of carcinogenic risks to humans. Some Industrial Chemicals. Vol. 60. IARC. p. 389–433.
  • Mager D. 2006. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med. 4(1):14.
  • Marquet P, Duncan SH, Chassard C, Bernalier-Donadille A, Flint HJ. 2009. Lactate has the potential to promote hydrogen sulphide formation in the human colon. FEMS Microbiol Lett. 299(2):128–134.
  • Martin P, Marcq I, Magistro G, Penary M, Garcie C, Payros D, Boury M, Olier M, Nougayrède J-P, Audebert M, et al. 2013. Interplay between siderophores and colibactin genotoxin biosynthetic pathways in Escherichia coli. PLoS Pathog. 9(7):e1003437.
  • Martin OCB, Olier M, Ellero-Simatos S, Naud N, Dupuy J, Huc L, Taché S, Graillot V, Levêque M, Bézirard V, et al. 2019. Haem iron reshapes colonic luminal environment: impact on mucosal homeostasis and microbiome through aldehyde formation. Microbiome. 7(1):72.
  • McClain M, Beckett A, Cover T. 2017. Helicobacter pylori vacuolating toxin and gastric cancer. Toxins. 9(10):316.
  • McClain MS, Cao P, Iwamoto H, Vinion-Dubiel AD, Szabo G, Shao Z, Cover TL. 2001. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol. 183(22):6499–6508.
  • Mezal EH, Bae D, Khan AA. 2014. Detection and functionality of the CdtB, PltA, and PltB from Salmonella enterica serovar Javiana. Pathog Dis. 72(2):95–103.
  • Michaud DS. 2013. Role of bacterial infections in pancreatic cancer. Carcinogenesis. 34(10):2193–2197.
  • Miller RA, Betteken MI, Guo X, Altier C, Duhamel GE, Wiedmann M. 2018. The typhoid toxin produced by the nontyphoidal Salmonella enterica serotype Javiana is required for induction of a DNA damage response in vitro and systemic spread in vivo. M Bio. 9(2):e00467–18.
  • Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, et al. 2015. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 1(5):653–661.
  • Molinari M, Salio M, Galli C, Norais N, Rappuoli R, Lanzavecchia A, Montecucco C. 1998. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med. 187(1):135–140.
  • Monteleone G, Pallone F, Stolfi C. 2012. The dual role of inflammation in colon carcinogenesis. Int J Mol Sci. 13(9):11071–11084.
  • Morgan RN, Saleh SE, Farrag HA, Aboulwafa MM. 2019. Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor-1 (CNF 1) in Escherichia coli: experimental and bioinformatics analyses. Gut Pathog. 11(1):22.
  • Mousa JJ, Yang Y, Tomkovich S, Shima A, Newsome RC, Tripathi P, Oswald E, Bruner SD, Jobin C. 2016. MATE transport of the E. coli-derived genotoxin colibactin. Nat Microbiol. 1:15009.
  • Nagaraja V, Eslick G. 2014. Systematic review with meta‐analysis: the relationship between chronic Salmonella typhi carrier status and gall‐bladder cancer. Aliment Pharmacol Ther. 39(8):745–750.
  • Nath G, Gulati AK, Shukla VK. 2010. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol. 16(43):5395–5404.
  • Neal JT, Peterson TS, Kent ML, Guillemin KH. 2013. H. pylori virulence factor CagA increases intestinal cell proliferation by Wnt pathway activation in a transgenic zebrafish model. Dis Model Mech. 6(3):802–810.
  • Neurath MF. 2019. IL-23 in inflammatory bowel diseases and colon cancer. Cytokine Growth Factor Rev. 45:1–8.
  • Nougayrède J-P, Taieb F, De Rycke J, Oswald E. 2005. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 13(3):103–110.
  • Nougayrède J-P, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E, et al. 2006. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 313(5788):848–851.
  • Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, et al. 2008. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA. 105(3):1003–1008.
  • O’Riordan JM, Abdel-Latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GSA, Keeling PWN, Kelleher D, Reynolds JV. 2005. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol. 100(6):1257–1264.
  • Orth JH, Lang S, Aktories K. 2004. Action of Pasteurella multocida toxin depends on the helical domain of Galphaq. J Biol Chem. 279(33):34150–34155.
  • Pagano JS, Blaser M, Buendia M-A, Damania B, Khalili K, Raab-Traub N, Roizman B. 2004. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 14(6):453–471.
  • Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. 2016. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 4(9):e609–e16.
  • Polk DB, Peek RM. 2010. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 10(6):403–414.
  • Preuss I, Hildebrand D, Orth JHC, Aktories K, Kubatzky KF. 2010. Pasteurella multocida toxin is a potent activator of anti-apoptotic signalling pathways . Cell Microbiol. 12(8):1174–1185.
  • Pumirat P, Broek CV, Juntawieng N, Muangsombut V, Kiratisin P, Pattanapanyasat K, Stevens JM, Stevens MP, Korbsrisate S. 2014. Analysis of the prevalence, secretion and function of a cell cycle-inhibiting factor in the melioidosis pathogen Burkholderia pseudomallei. PLoS One. 9(5):e96298.
  • Raisch J, Buc E, Bonnet M, Sauvanet P, Vazeille E, de Vallée A, Déchelotte P, Darcha C, Pezet D, Bonnet R, et al. 2014. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol. 20(21):6560–6572.
  • Rippere-Lampe KE, Lang M, Ceri H, Olson M, Lockman HA, O’Brien A. 2001. Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect Immun. 69(10):6515–6519.
  • Rippere-Lampe KE, O’Brien AD, Conran R, Lockman HA. 2001. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli. Infect Immun. 69(6):3954–3964.
  • Rozengurt E, Higgins T, Chanter N, Lax AJ, Staddon JM. 1990. Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc Natl Acad Sci U S A. 87(1):123–127.
  • Russell WR, Gratz SW, Duncan SH, Holtrop G, Ince J, Scobbie L, Duncan G, Johnstone AM, Lobley GE, Wallace RJ, et al. 2011. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr. 93(5):1062–1072.
  • Sahai E, Marshall CJ. 2002. RHO-GTPases and cancer. Nat Rev Cancer. 2(2):133–142.
  • Samba‐Louaka A, Nougayrède JP, Watrin C, Jubelin G, Oswald E, Taieb F. 2008. Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21 and p27. Cell Microbiol. 10(12):2496–2508.
  • Satin B, Norais N, Telford J, Rappuoli R, Murgia M, Montecucco C, Papini E. 1997. Effect of Helicobacter pylori vacuolating toxin on maturation and extracellular release of procathepsin D and on epidermal growth factor degradation. J Biol Chem. 272(40):25022–25028.
  • Schistosomes, liver flukes and Helicobacter pylori. 1994. IARC working group on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum. 61:1–241.
  • Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K. 1997. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature. 387(6634):725–729.
  • Schmidt G, Selzer J, Lerm M, Aktories K. 1998. The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity cysteine 866 and histidine 881 are essential for enzyme activity. J Biol Chem. 273(22):13669–13674.
  • Sears CL. 2009. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev. 22(2):349–369.
  • Sears CL, Garrett WS. 2014. Microbes, microbiota, and colon cancer. Cell Host Microbe. 15(3):317–328.
  • Sfanos KS, De Marzo AM. 2012. Prostate cancer and inflammation: the evidence. Histopathology. 60(1):199–215.
  • Shenker BJ, Datar S. 1995. Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle. Infect Immun. 63(12):4830–4836.
  • Shenker BJ, Ojcius DM, Walker LP, Zekavat A, Scuron MD, Boesze-Battaglia K. 2015. Aggregatibacter actinomycetemcomitans cytolethal distending toxin activates the NLRP3 inflammasome in human macrophages, leading to the release of proinflammatory cytokines. Infect Immun. 83(4):1487–1496.
  • Shield KD, Marant Micallef C, de Martel C, Heard I, Megraud F, Plummer M, Vignat J, Bray F, Soerjomataram I. 2018. New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis. Eur J Epidemiol. 33(3):263–274.
  • Simmonds RE, Lali FV, Smallie T, Small PL, Foxwell BM. 2009. Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism. J Immunol. 182(4):2194–2202.
  • Spanò S, Ugalde JE, Galán JE. 2008. Delivery of a Salmonella typhi exotoxin from a host intracellular compartment. Cell Host Microbe. 3(1):30–38.
  • Staddon JM, Chanter N, Lax A, Higgins TE, Rozengurt E. 1990. Pasteurella multocida toxin, a potent mitogen, stimulates protein kinase C-dependent and -independent protein phosphorylation in Swiss 3T3 cells. J Biol Chem. 265(20):11841–11848.
  • Stoll T, Markwirth G, Reipschläger S, Schmidt G. 2009. A new member of a growing toxin family-Escherichia coli cytotoxic necrotizing factor 3 (CNF3). Toxicon. 54(6):745–753.
  • Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD, Smyth MJ. 2008. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci USA. 105(2):652–656.
  • Taieb F, Petit C, Nougayrède J-P, Oswald E, Donnenberg MS. 2016. The Enterobacterial genotoxins: cytolethal distending toxin and colibactin. EcoSal Plus. 7(1). DOI:https://doi.org/10.1128/ecosalplus.ESP-0008-2016.
  • Tan S, Noto JM, Romero-Gallo J, Peek RM, Jr, Amieva MR. 2011. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog. 7(5):e1002050.
  • Tezal M, Sullivan MA, Reid ME, Marshall JR, Hyland A, Loree T, Lillis C, Hauck L, Wactawski-Wende J, Scannapieco FA, et al. 2007. Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg. 133(5):450–454.
  • Thomas W, Ascott ZK, Harmey D, Slice LW, Rozengurt E, Lax AJ. 2001. Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 gene. Infect Immun. 69(11):6839–6845.
  • Tommasino M. 2014. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 26:13–21.
  • Toro TB, Toth JI, Petroski MD. 2013. The cyclomodulin cycle inhibiting factor (CIF) alters cullin neddylation dynamics. J Biol Chem. 288(21):14716–14726.
  • Torres VJ, Ivie SE, McClain MS, Cover TL. 2005. Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin. J Biol Chem. 280(22):21107–21114.
  • Tsugawa H, Suzuki H, Saya H, Hatakeyama M, Hirayama T, Hirata K, Nagano O, Matsuzaki J, Hibi T. 2012. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe. 12(6):764–777.
  • Vaca C, Wilhelm J, Harms-Ringdahl M. 1988. Interaction of lipid peroxidation products with DNA. A review. Mutation Res/Rev Genetic Toxicol. 195(2):137–149.
  • Walker KE, Weiss AA. 1994. Characterization of the dermonecrotic toxin in members of the genus Bordetella. Infect Immun. 62(9):3817–3828.
  • Wallace SS. 2002. Biological consequences of free radical-damaged DNA bases. Free Radic Biol Med. 33(1):1–14.
  • Wang F, Meng W, Wang B, Qiao L. 2014. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 345(2):196–202.
  • Ward JF, Blakely WF, Joner EI. 1985. Mammalian cells are not killed by DNA single-strand breaks caused by hydroxyl radicals from hydrogen peroxide. Radiat Res. 103(3):383–392.
  • White MK, Pagano JS, Khalili K. 2014. Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev. 27(3):463–481.
  • Wilson BA, Aminova LR, Ponferrada VG, Ho M. 2000. Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin. Infect Immun. 68(8):4531–4538.
  • Wilson BA, Zhu X, Ho M, Lu L. 1997. Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1. J Biol Chem. 272(2):1268–1275.
  • Windey K, De Preter V, Verbeke K. 2012. Relevance of protein fermentation to gut health. Mol Nutr Food Res. 56(1):184–196.
  • Xiong H, Du W, Sun T-T, Lin Y-W, Wang J-L, Hong J, Fang J-Y. 2014. A positive feedback loop between STAT3 and cyclooxygenase-2 gene may contribute to Helicobacter pylori-associated human gastric tumorigenesis. Int J Cancer. 134(9):2030–2040.
  • Xu M, Mizoguchi I, Morishima N, Chiba Y, Mizuguchi J, Yoshimoto T. 2010. Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. Clin Dev Immunol. 2010:1–9.
  • Yamaoka Y, Osato MS, Sepulveda AR, Gutierrez O, Figura N, Kim JG, Kodama T, Kashima K, Graham DY. 2000. Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect. 124(1):91–96.
  • Yan J, Smyth MJ, Teng MW. 2018. Interleukin (IL)-12 and IL-23 and their conflicting roles in cancer. Cold Spring Harb Perspect Biol. 10(7):a028530.
  • Ye D, Willhite DC, Blanke SR. 1999. Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin. J Biol Chem. 274(14):9277–9282.
  • Yeh E, Kohli RM, Bruner SD, Walsh CT. 2004. Type II thioesterase restores activity of a NRPS module stalled with an aminoacyl-S-enzyme that cannot be elongated. Chembiochem. 5(9):1290–1293.
  • Yokoyama K, Higashi H, Ishikawa S, Fujii Y, Kondo S, Kato H, Azuma T, Wada A, Hirayama T, Aburatani H, et al. 2005. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc Natl Acad Sci USA. 102(27):9661–9666.
  • Yu H, Kortylewski M, Pardoll D. 2007. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol. 7(1):41–51.
  • Zeisel SH, Warrier M. 2017. Trimethylamine N-oxide, the microbiome, and heart and kidney disease. Annu Rev Nutr. 37:157–181.
  • Zhang Z, Aung KM, Uhlin BE, Wai SN. 2018. Reversible senescence of human colon cancer cells after blockage of mitosis/cytokinesis caused by the CNF1 cyclomodulin from. Sci Rep. 8(1):17780.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.